No material information; no immediate trading implications. Monitor for future Form 4 filings for potential insider transactions.
ZYME drugs
ZYME drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 18 $24.43entry
- T+1 · 6mo ago −0.12%α +0.53% · $24.40
- T+5 · 6mo ago +3.97%α +2.35% · $25.40
- T+20 · 5mo ago −7.94%α −9.52% · $22.49
- T+60 · 3mo ago +2.05%α −2.80% · $24.93
Price Chart
How similar events traded
Executive Summary
Form 3 filing for Paul R. Schneider, EVP and General Counsel of Zymeworks Inc., reports zero beneficial ownership. This is a routine initial ownership statement with no material impact on the company's financials or stock.
Key Facts
- Paul R. Schneider appointed EVP, General Counsel of Zymeworks Inc.
- Initial beneficial ownership filing (Form 3) reports no securities owned.
Financial Impact
Not specified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-227111 |
| Document: 0001193125-26-227111-index-headers.html | 0001193125-26-227111 |
| Document: 0001193125-26-227111-index.html | 0001193125-26-227111 |
| Document: 0001193125-26-227111.txt | 0001193125-26-227111 |
Track record
25 reports on ZYME
6 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +16.72% at T+60 after the Jun 14, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 16, 2026today 8-K Neutral 4/10 Entry price pending
- Nov 16, 2026today Press Release Neutral 4/10 Entry price pending
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $26.24 Now $26.24 −0.00% settles Dec 14
- Nov 9, 20267d ago 8-K/A Neutral 5/10 Entry $31.46 Now $26.24 −16.59% settles Dec 9
- Nov 9, 20267d ago Press Release Bullish 6/10 Entry $31.46 Now $26.24 −16.59% settles Dec 9
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $30.94 Now $26.24 −15.19% settles Dec 3
- Oct 26, 202621d ago DEFA14A Neutral 2/10 Entry $28.85 Now $26.24 −9.05% settles Nov 24
- Oct 26, 202621d ago DEF 14A Neutral 3/10 Entry $28.85 Now $26.24 −9.05% settles Nov 24
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $28.22 Now $26.24 −7.02% settles Nov 20
- Oct 15, 20264w ago Press Release Neutral 1/10 Entry $25.75 to $29.07 Now $26.24 +1.90% ▲ +12.89% +14.31% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers